We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Phase 1b trial assesses safety and pharmacokinetics of VS-01 in liver cirrhosis patients, suggesting potential benefits.
Versantis AG.
No takes yet. Share an insight, caveat, or question.
Uschner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: